Short Dual Antiplatelet Therapy in High Bleeding Risk Patients

Capodanno, Davide; Greco, Antonio

doi:10.1016/j.jcin.2023.08.037

JACC: Cardiovascular Interventions

2023

DOI: 10.1016/j.jcin.2023.08.037

|View full text |Cite

Short Dual Antiplatelet Therapy in High Bleeding Risk Patients

Davide Capodanno,

Antonio Greco

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis

Greco,

Scalia,

Laudani

et al. 2025

International Journal of Cardiology

View full text Add to dashboard Cite

Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis

Greco,

Scalia,

Laudani

et al. 2025

International Journal of Cardiology

View full text Add to dashboard Cite

Stent type selection in high bleeding risk patients

Greco,

Spagnolo,

Capodanno

2024

Expert Review of Medical Devices

View full text Add to dashboard Cite

Periprocedural myocardial infarction and injury

Spagnolo,

Occhipinti,

Laudani

et al. 2024

European Heart Journal: Acute Cardiovascular Care

View full text Add to dashboard Cite

Periprocedural myocardial infarction (PMI) and injury, pertinent to both cardiac and non-cardiac procedures, have gained increasing recognition in clinical practice. Over time, diverse definitions for diagnosing PMI have been developed and validated among patient populations undergoing coronary revascularization. However, this variety in definitions presents considerable challenges in clinical settings and complicates both the design and interpretation of clinical trials. The necessity to accurately diagnose PMI has spurred significant interest in establishing universally accepted and prognostically meaningful thresholds for cardiac biomarkers elevation and supportive ancillary criteria. In fact, elevations in cardiac biomarkers in line with the 4th Universal Definition of Myocardial Infarction, have been extensively confirmed to be associated with increased mortality and cardiovascular events. In the context of non-coronary cardiac procedures, such as Transcatheter Aortic Valve Implantation, there is a growing acknowledgment of both the high incidence rates and the adverse impact of PMI on patient outcomes. Similarly, emerging research underscores the significance of PMI and injury in non-cardiac surgery, highlighting the urgent need for effective prevention and risk management strategies in this domain.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Short Dual Antiplatelet Therapy in High Bleeding Risk Patients

Cited by 3 publications

References 14 publications

Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis

Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis

Stent type selection in high bleeding risk patients

Periprocedural myocardial infarction and injury

Contact Info

Product

Resources

About